HYPERTENSION, THE SILENT KILLER   Hypertension is a pervasive problem and affects nearly 50% of the US population including over 90 million adults with uncontrolled hypertension and an estimated 34 million untreated. For an adult 40 years of age without high blood pressure, the lifetime risk of developing hypertension is 93% for African Americans, 92% for […]

THE HDL CHOLESTEROL CONUNDRUM  The role of High-density lipoprotein (HDL) cholesterol in the development of atherosclerosis and cardiovascular (CV) morbidity and mortality has long been recognized. Epidemiological studies have demonstrated an inverse relationship between HDL cholesterol and CV events. HDL is incorporated in the calculation of the 10-yr ASCVD risk in patients who have never […]

This article was written in collaboration with Dr. John J.P. Kastelein, M.D., Ph.D., FESC.Professor of Medicine, University of Amsterdam. NON-STATIN THERAPIES FOR LDL CHOLESTEROL LOWERING The role of statin in the treatment of patients with atherosclerotic cardiovascular disease (ASCVD) has been well demonstrated to lower major cardiovascular events. It is the number one recommendation by […]

This article was written in collaboration with Dr. Leslie Cho, MD.Director of the Cleveland Clinic’s Women’s Cardiovascular Center. Lp (a) OR LIPOPROTEIN (a), A BIOMARKER FOR HEART DISEASE AND STROKE Cardiovascular disease remains the leading cause of death and disability worldwide. Despite advances in lipid management, there remain significant risks of heart disease and stroke […]